amiodarone has been researched along with Cardiac Death in 3 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "EPS was performed 1 month after starting amiodarone, and Holter-monitoring was recorded before and 1 month after amiodarone in 188 patients with sustained VT/VF because of structural heart diseases." | 9.13 | Electrophysiologic study-guided amiodarone for sustained ventricular tachyarrhythmias associated with structural heart diseases. ( Aiba, T; Aihara, N; Kamakura, S; Kurita, T; Noda, T; Okamura, H; Satomi, K; Shimizu, W; Suyama, K; Taguchi, A; Yamagata, K, 2008) |
| "EPS was performed 1 month after starting amiodarone, and Holter-monitoring was recorded before and 1 month after amiodarone in 188 patients with sustained VT/VF because of structural heart diseases." | 5.13 | Electrophysiologic study-guided amiodarone for sustained ventricular tachyarrhythmias associated with structural heart diseases. ( Aiba, T; Aihara, N; Kamakura, S; Kurita, T; Noda, T; Okamura, H; Satomi, K; Shimizu, W; Suyama, K; Taguchi, A; Yamagata, K, 2008) |
| "The European Myocardial Infarct Amiodarone Trial (EMIAT) investigated the effects of amiodarone versus placebo in patients after myocardial infarction who had left ventricular ejection fraction | 3.73 | Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial). ( Badilini, F; Benchetrit, C; Coumel, P; Leenhardt, A; Maisonblanche, P; Milliez, P; Siliste, C; Vicaut, E, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunetti, L | 1 |
| Lee, SM | 1 |
| Nahass, RG | 1 |
| Suh, D | 1 |
| Miao, B | 1 |
| Bucek, J | 1 |
| Kim, D | 1 |
| Kim, OK | 1 |
| Suh, DC | 1 |
| Milliez, P | 1 |
| Leenhardt, A | 1 |
| Maisonblanche, P | 1 |
| Vicaut, E | 1 |
| Badilini, F | 1 |
| Siliste, C | 1 |
| Benchetrit, C | 1 |
| Coumel, P | 1 |
| Aiba, T | 1 |
| Yamagata, K | 1 |
| Shimizu, W | 1 |
| Taguchi, A | 1 |
| Satomi, K | 1 |
| Noda, T | 1 |
| Okamura, H | 1 |
| Suyama, K | 1 |
| Aihara, N | 1 |
| Kamakura, S | 1 |
| Kurita, T | 1 |
1 trial available for amiodarone and Cardiac Death
| Article | Year |
|---|---|
Electrophysiologic study-guided amiodarone for sustained ventricular tachyarrhythmias associated with structural heart diseases.
Topics: Aged; Amiodarone; Death; Electrocardiography, Ambulatory; Electrophysiologic Techniques, Cardiac; Fe | 2008 |
2 other studies available for amiodarone and Cardiac Death
| Article | Year |
|---|---|
The risk of cardiac events in patients who received concomitant levofloxacin and amiodarone.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Body Mass Index; Death; Drug Thera | 2019 |
Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Death; Electrocard | 2005 |